Publication | Closed Access

Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients

InflammationMetabolic SyndromeNon-diabetic Stemi PatientsDiabetes ManagementCardiovascular DiseaseMicrovascular DysfunctionDiabetesImmunologyDecreased Endothelial FunctionVascular BiologyDiabetes MellitusHyperglycemiaHigh Inflammatory ResponseMedicineAtherosclerosis